INTRODUCTION
The diagnosis of bile duct and gallbladder cancer is difficult and the prognosis of both types of cancer is poor. 1 The overall 5-year survival rate of gallbladder cancer is <5%, and the natural history of unresectable cholangiocarcinoma results in no survival at year 5. [2] [3] [4] Currently, only surgical resection with appropriate lymph node dissection remains as
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The Korean Journal of Gastroenterology the curative approach in some patients. [5] [6] [7] An extensive work-up that includes diagnostic imaging modalities, such as ultrasonography, CT, MRI, and endoscopic measures, is essential for accurate tumor staging and treatment decisions. 8 However, differential diagnosis based solely on structural imaging information remains challenging because of its variable reliability and lack of information on its effect on predicting and improving prognosis.
2-[ 18 F]-Fluoro-2-deoxy-D-glucose (FDG) PET-CT that provides metabolic and anatomic information of malignant cells
simultaneously is a relatively new and accurate diagnostic approach in various malignancies. Several studies have described the usefulness of PET-CT in the detecting and staging of bile duct and gallbladder cancer. [8] [9] [10] In these studies, the FDG PET-CT measured the maximum standardized uptake value (SUVmax), a semiquantitative simplified measurement of tissue deoxyglucose metabolic rate. A few retrospective studies have explored the survival prognostic significance of the primary tumor SUVmax in various malignancies. [11] [12] [13] In bile duct and gallbladder cancer, fewer studies have been conducted to evaluate the prognostic value of primary tumor SUVmax and most of these reports included only a small number of patients.
14-16
So, we performed a retrospective analysis from prospective data to determine the prognostic value of primary tumor SUVmax for patients with bile duct and gallbladder cancer.
MATERIALS AND METHODS

Patients
Sixty-one patients who were diagnosed with bile duct and gallbladder cancer and underwent FDG PET-CT in Kangbuk 24 hours before and after performing PET-CT, as cholangitis patient. 20 The institutional review board approved this retrospective study and waived patient consent for this specific study (KBC13065).
FDG PET-CT
All patients fasted for at least 6 hours before 18 SUVmax=C (kBq/mL)/ID (kBq)/body weight (kg) where C is the tissue activity concentration measured by PET and ID is the injected dose. All CT images were viewed separately to identify additional lesions without FDG uptake using soft tissue, lung, and bone window leveling.
Statistical analyses
Patients were stratified and analyzed using with regard to 
RESULTS
Characteristics of all patients
The patient characteristics are summarized in Table 1 . The Youden index showed that the optimal cutoff value of primary tumor SUVmax for predicting survival was 5.5. Using primary tumor SUVmax of 5.5 yielded a sensitivity 69.2% and a specificity 77.3%. There was no significant association between primary tumor SUVmax and cholangitis (p=0.699). Axial FDG PET-CT images of two patients with common bile duct cancer who received nonsurgical treatment. Primary tumor maximum standardized uptake value is 3.1 (arrow) in 69-year-old man who was alive 26 months after diagnosis (A), and 9.9 (arrow) in 76-year-old man who died 10 months after diagnosis (B), respectively.
Prognostic factors of bile duct and gallbladder cancer
In all 61 patients, the overall median survival was 10 There is a possibility of inflammatory effect because the coexisting active inflammatory condition can result in a false-positive FDG uptake. 9 In the present study, we found no significant correlation between primary tumor SUVmax and presence of cholangitis at the time of performing PET-CT.
Kitamura et al. 15 reported there are no marked inflammatory effect on FDG uptake in patients with extrahepatic bile duct cancer.
Various studies have assessed whether the primary tumor SUVmax can be used to predict the survival of patients with other malignancies. In lung cancer, breast cancer, malignant lymphoma, endometrial cancer and early cervical cancer, studies showed that primary tumor SUVmax on FDG-PET was an independent and significant prognostic value on multivariate analysis. [11] [12] [13] [21] [22] [23] A similar study evaluated the correlation between FDG uptake and prognosis for patients with bile duct and gallbladder cancer. 14 The results showed that high SUVmax was associated with poor overall survival on univariate analysis but was not independently associated with prognosis on multivariate analysis. Kitamura et al. 15 reported that SUVmax on FDG PET is an independent predictor of survival in patients with extrahepatic bile duct cancer on multivariate analysis. Seo et al. 16 described that SUVmax is a significant predictor of disease free survival, not overall survival, for patients with mass-forming IDBC. In all of these studies, . 24 The overexpression of Glut-1 is associated with depth of invasion and increased incidence of lymph node and hepatic metastasis in colorectal cancer, 25 increased proliferation of glioma 26 and worsened prognosis in non-small cell lung cancer. 27 However, no report has assessed the association of up-regulation of Glut-1 with the prognosis in bile duct and gallbladder cancer. Further study is needed to clarify the relationship between the overexpression of Glut-1 and cell proliferation, malignant potential, and prognosis of bile duct and gallbladder cancer.
Increased FDG uptake may be associated with advanced stage. Some authors reported that a high SUVmax of primary tumors is significantly related to higher stage in various cancers. 12, 22, 23, 25 In bile duct cancer, one study reported a significant association between high SUVmax and advanced pathologic stage. 14 In this study, the pathologic stage was also independently associated poor overall survival in multivariate analysis. However, in our study, high SUVmax was associated with poor overall survival regardless of advanced stage in multivariate analysis.
Some evidence indicates that high FDG uptake is associated with recurrence in lung cancer and IBDC. 16, 22 In mass-forming IBDC, the disease-free survival of patients with a high primary tumor SUV was significantly worse than those with a low SUV. 16 Although we have no more detailed information for postoperative recurrence in our study, recurrence might be a contributory factor of poor survival.
Recurrent malignant cancer cells tend to be more aggressive and resistant to palliative treatment.
There are several limitations in this study. Although we used prospective database by using a single PET-CT instrument, this study is a retrospective study. We could not eval- In conclusion, primary tumor SUVmax measured using FDG PET-CT is an independent and significant prognostic factor for overall survival in patients with bile duct and gallbladder cancer. Prospective analyses with larger numbers of cases are warranted for confirmation.
